Net gamma exposure for Lantheus Holdings Inc (LNTH) options was positive at the Nov 4, 2026 close, about $423.27K per 1% move in the stock. It has been positive on 20 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for LNTH, 2026-11-20(m), calls & puts
Gamma Exposure Stats
Showing results for LNTH, 2026-11-20(m), calls & puts
Net Gamma Exposure by Expiration
Showing results for LNTH, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
LNTH Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is LNTH gamma exposure positive or negative?
Lantheus net gamma exposure was positive on Nov 4, 2026, at $423.27K. It has been positive on 20 of the last 20 trading days.
How has LNTH gamma exposure changed recently?
Lantheus net gamma exposure went from $699.15K on Oct 7, 2026 to $423.27K on Nov 4, 2026. See the LNTH gamma exposure history for a longer view.
What is Lantheus Holdings Inc?
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes.